Clinical studies recruiting near Xinxiang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · The Third Affiliated Hospital of Xinxiang Medical University · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Phase 1/Phase 2 · The First Affiliated Hospital of Xinxiang Medical University · Lin BioScience, Inc · NCT05756322 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The First Affiliated Hospital of Xinxiang Medical University · Shanghai Henlius Biotech · NCT07160335 HUMSCs Combined With Col I to Third-Degree Burn Wound
Phase 1/Phase 2 · The First Affiliated Hospital of Xinxiang Medical College · The First Affiliated Hospital of Xinxiang Medical College · NCT07530003 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · The First Affiliated Hospital of Xinxiang Medical University · RemeGen Co., Ltd. · NCT07105215 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Xinxiang Central Hospital · Boehringer Ingelheim · NCT06531824 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Phase 3 · Xinxiang Central Hospital · Beletalent (Zhuhai) Pharmaceutical Co., Ltd · NCT06817265 A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-pos
Phase 1/Phase 2 · The First Affiliated Hospital of Henan Medical Hospital · Antengene Biologics Limited · NCT07327229 Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post
Phase 3 · The First Affiliated Hospital of Henan Medical University · Capital Medical University · NCT07509645 Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects
NA · The First Affiliated Hospital of Xinxiang Medical College · The First Affiliated Hospital of Xinxiang Medical College · NCT07066228 Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Phase 2 · The First Affiliated Hospital of Xinxiang Medical University · InSilico Medicine Hong Kong Limited · NCT07265570 A Study of MI078 for Postpartum Depression
Phase 3 · The Second Affiliated Hospital of Xinxiang Medical Universit · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · The Third Affiliated Hospital of Xinxiang Medical University · Pfizer · NCT06629779 Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Phase 3 · Huixian People's Hospital · Beijing Tiantan Hospital · NCT06157502 A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic S
Phase 2 · Local Institution - 0152 · Bristol-Myers Squibb · NCT07492680 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · The First Affiliated Hospital of Xinxiang Medical University · Bristol-Myers Squibb · NCT06561386 ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immuno
Phase 2 · The First Affiliated Hospital of Xinxiang Medical University · Second Xiangya Hospital of Central South University · NCT06951646 eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339 Clinical Transformation of Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Ava
NA · The First Affiliated Hospital of Xinxiang Medical College · The First Affiliated Hospital of Xinxiang Medical College · NCT07101562 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
Phase 3 · Xinxiang Central hospital · Ganzhou Hemay Pharmaceutical Co., Ltd · NCT06145893 A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors
Phase 1 · The First Affiliated Hospital of Xinxiang Medical University · Henan Genuine Biotech Co., Ltd. · NCT07229898 A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
Phase 3 · The First Affiliated Hospital of Xinxiang Medical University · Takeda · NCT07217301 Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIR
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06133972 Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Phase 2 · The First Affiliated Hospital of Xinxiang Medical University · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06421376 A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate,
Phase 1 · The First Affiliated Hospital of Xinxiang Medical University · BeOne Medicines · NCT06625593 ICP-332 in Subjects With Non-segmental Vitiligo
Phase 2/Phase 3 · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07047612 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2)
Phase 3 · The First Affiliated Hospital of Xinxiang Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07043725 Phase IIa Study for IPG11406 in Patients With Lupus Nephritis
Phase 1/Phase 2 · Xinxiang Central Hospital · Nanjing Immunophage Biotech Co., Ltd · NCT06717815

Look up another city

Look up another condition